Multivariate Approach Reveals Complex Genetic Pathways Underlying Alzheimer's

While the exact cause remains unclear, genetics plays a significant role in the development of Alzheimer's disease. Traditional analyses to identify Alzheimer's genes have used a "case-control design," which can oversimplify complex genetic interactions. A recent study led by Prof. Dr. Lars Bertram at the University of Lübeck utilized a more comprehensive approach, combining data from five different Alzheimer's biomarkers to gain deeper insights.

By integrating these biomarkers, the research team conducted advanced downstream analyses that revealed previously unknown aspects of Alzheimer's disease. One discovery pointed to reduced expression of GRIN2D, a brain messenger glutamate receptor, in Alzheimer's disease and other neuropsychiatric disorders. This reduced expression may impair synaptic function, impacting how nerve cells communicate in the brain.

Additionally, mediation analyses suggested two main pathways contributing to Alzheimer's disease. One pathway involved amyloid and tau proteins, known contributors to the disease, mediated by the Alzheimer's risk gene APOE. The second pathway was closely linked to the immune system's response, influenced by genes TMEM106B and CHI3L1, which are involved in cellular component transport and inflammatory response regulation.

The study, published in Genome Medicine, also examined the role of the X chromosome and sex-specific genome-wide analyses, shedding light on the differing Alzheimer's disease frequencies between men and women. Certain genes were found to affect Alzheimer's biomarkers exclusively in one gender, with some genes showing opposing effects, increasing the risk in one gender while decreasing it in the other.

This research highlights new approaches to understanding Alzheimer's disease causes. The multivariate analysis of combined biomarkers offers potential benefits for earlier diagnosis and a deeper understanding of the disease. Further validation in independent studies is necessary to confirm these findings, but this study provides valuable insights into Alzheimer's disease complexity and potential future diagnostic improvements.